1-4 of 4
Authors: Patrick Mercié
Sort by
Journal Article
Maraviroc plus raltegravir failed to maintain virological suppression in HIV-infected patients with lipohypertrophy: results from the ROCnRAL ANRS 157 study
Get access
Christine Katlama and others
Journal of Antimicrobial Chemotherapy, Volume 69, Issue 6, June 2014, Pages 1648–1652, https://doi.org/10.1093/jac/dkt536
Published: 16 February 2014
Journal Article
Lopinavir/ritonavir monotherapy versus current treatment continuation for maintenance therapy of HIV-1 infection: the KALESOLO trial
Get access
Jean-Luc Meynard and others
Journal of Antimicrobial Chemotherapy, Volume 65, Issue 11, November 2010, Pages 2436–2444, https://doi.org/10.1093/jac/dkq327
Published: 15 September 2010
Journal Article
A randomized trial of two-drug versus three-drug tenofovir-containing maintenance regimens in virologically controlled HIV-1 patients
Get access
Pierre-Marie Girard and others
Journal of Antimicrobial Chemotherapy, Volume 64, Issue 1, July 2009, Pages 126–134, https://doi.org/10.1093/jac/dkp141
Published: 29 April 2009
Journal Article
Virological and immunological response in HIV-1-infected patients with multiple treatment failures receiving raltegravir and optimized background therapy, ANRS CO3 Aquitaine Cohort
Get access
Linda Wittkop and others
Journal of Antimicrobial Chemotherapy, Volume 63, Issue 6, June 2009, Pages 1251–1255, https://doi.org/10.1093/jac/dkp114
Published: 31 March 2009
Advertisement intended for healthcare professionals
Advertisement intended for healthcare professionals